CytoDyn

CytoDyn is advancing targeted therapies to address cancer, HIV and other autoimmune diseases, with the goal of improving the quality of life for patients.

[Jim Dwyer MD @JimDwyerMD]

Two good friends recently saved by monoclonal antibody treatment. Unvaccinated friend with multiple sclerosis lucky to get REGEN-COV in nick of time. Fully vaccinated ER Doc friend dying in ICU got "Leronlimab" (compassionate use) and got better in 24hrs - now out of hospital ❤️

[Proactive USA @proactive_NA]

$CYDY CytoDyn granted US patent for methods of treating coronavirus infection with leronlimab https://t.co/quePJsDfy1 @CytoDyn #CYDY

[Proactive USA @proactive_NA]

$CYDY CytoDyn's flagship drug leronlimab included in Nature Communications' study on HIV prevention https://t.co/SsCyd8c1Ch @CytoDyn #CYDY

[Proactive USA @proactive_NA]

$CYDY CytoDyn receives order from Chiral Pharma to use Vyrologix on COVID-19 patients in the Philippines https://t.co/DOPM5OutIb @CytoDyn #CYDY

[Proactive USA @proactive_NA]

$CYDY CytoDyn forms supply and distribution deal with Indian firm for leronlimb as coronavirus treatment https://t.co/3nre6rCSco @CytoDyn #CYDY

[Proactive USA @proactive_NA]

$CYDY CytoDyn CEO talks through recent $50M convertible debt financings efforts https://t.co/qvkbtvdO2D @CytoDyn #CYDY

[Proactive USA @proactive_NA]

$CYDY CytoDyn updates investors on the status of its coronavirus and NASH-focused clinical trials https://t.co/md2MpLEcl9 @CytoDyn #CYDY

[Proactive USA @proactive_NA]

$CYDY CytoDyn provide update on their path to approval for treatment of COVID-19 https://t.co/T2VbG7yDGz via @proactive_NA @CytoDyn #CYDY @OTCMarkets #OTCQB

[Thomas Landstreet @TomLandstreet]

What if COVID-19 was just a bad cold? An underdog Covid-19 therapeutic called Leronlimab, following statistically significant trial results, is set to change the course of the pandemic.

$cydy $gild #leronlimab $rlftf

https://t.co/gM8BgdJlu0

[Proactive USA @proactive_NA]

$CYDY CytoDyn reveals latest mild-to-moderate coronavirus patient data in Phase 2 trial https://t.co/rYeBT86JGO via @proactive_NA @CytoDyn #CYDY @OTCMarkets #OTCQB

[Proactive USA @proactive_NA]

$CYDY CytoDyn to submit request for pre-submission meetings in U.K. for Leronlimab https://t.co/RAGa8mAXsR via @proactive_NA @CytoDyn #CYDY @OTCMarkets #OTCQB

[Proactive USA @proactive_NA]

$CYDY CytoDyn’s Leronlimab receives positive DSMC recommendation in ongoing Phase 3 study https://t.co/fLJb5lsqKz via @proactive_NA @CytoDyn #CYDY @OTCMarkets #OTCQB

[Proactive USA @proactive_NA]

$CYDY CytoDyn addresses negative claims made by healthcare publication STAT on its coronavirus study https://t.co/PHtvgOorp7 via @proactive_NA @CytoDyn #CYDY @OTCMarkets #OTCQB

[Proactive USA @proactive_NA]

$CYDY CytoDyn showcases its patient safety data from its Phase 2 coronavirus trial https://t.co/57uGYkGG5A via @proactive_NA @CytoDyn #CYDY @OTCMarkets #OTCQB

[Proactive USA @proactive_NA]

$CYDY CytoDyn files to uplist to the Nasdaq, updates on coronavirus trials https://t.co/N5jZu6mcid via @proactive_NA @CytoDyn #CYDY @OTCMarkets #OTCQB

[Dr. Mobeen Syed @drbeen_medical]

Exciting news.

I will have the CEO of CytoDyn as a guest to discuss Leronlimab with #koolbeens on this Saturday.

[Proactive USA @proactive_NA]

$CYDY CytoDyn CEO calls Citron Research report 'false', updates on coronavirus clinical trials https://t.co/ZFpNAoPHiP via @proactive_NA @CytoDyn #CYDY @OTCMarkets #OTCQB

[Seeking Alpha @SeekingAlpha]

$CYDY - Don't Forget Cytodyn's Other Prospects. https://t.co/ssD5PK1eGq #stocks #markets #economy

[Montefiore Health System @MontefioreNYC]

What is leronlimab? Learn more about Dr. Harish Seethramraju’s research on the drug as a potential treatment for #COVID19 via @thisisthebronx: https://t.co/GrXe6Wtj4S #HealthcareHeroes

[Montefiore Health System @MontefioreNYC]

#cytokinestorms have inflamed & damaged the organs of many #COVID19 patients. In two separate trials, Montefiore & @EinsteinMed were the first site to investigate anti-inflammatory drug leronlimab’s ability to prevent these storms: https://t.co/rrVdeV0aLe